Eyes on EU's Alzheimer's disease market; how horizon scanning predicts the future
Aduhelm’s US launch has prompted a new look into what is in store for the Alzheimer’s disease market in the EU over the coming years.
Stay updated with breaking news from Pharmaceutical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aduhelm’s US launch has prompted a new look into what is in store for the Alzheimer’s disease market in the EU over the coming years.
The global Covid death toll has passed 5.8 million, with a figure of 5,826,582 according to researchers at Johns Hopkins University.
Vaccines are working and treatments are advancing, so the likelihood of surviving Covid-19 is improving around the world.
Hospitals and pharmacies are required to toss expired drugs, no matter how expensive or vital. Meanwhile the FDA has long known that many remain safe and potent for years longer.
Daily infections are nearing the quarter million mark in Germany, as the country reported 247,862 new Covid-19 cases.